APA (7th ed.) Citation

Biglari, B., Büchler, A., Swing, T., Biehl, E., Roth, H. J., Bruckner, T., . . . Moghaddam-Alvandi, A. (2013). Increase in soluble CD95L during subacute phases after human spinal cord injury: A potential therapeutic target. Spinal cord, 51(3), . https://doi.org/10.1038/sc.2012.139

Chicago Style (17th ed.) Citation

Biglari, Bahram, et al. "Increase in Soluble CD95L During Subacute Phases After Human Spinal Cord Injury: A Potential Therapeutic Target." Spinal Cord 51, no. 3 (2013). https://doi.org/10.1038/sc.2012.139.

MLA (9th ed.) Citation

Biglari, Bahram, et al. "Increase in Soluble CD95L During Subacute Phases After Human Spinal Cord Injury: A Potential Therapeutic Target." Spinal Cord, vol. 51, no. 3, 2013, https://doi.org/10.1038/sc.2012.139.